Dr. Joseph Shrager practices all aspects of thoracic surgery but has specials interest and experience in lung cancer, surgery for emphysema, and mediastinal diseases. His clinical publications reflect these interests. In all cases, he looks towards minimally invasive approaches where appropriate, including VATS (thoracoscopic) lobectomy for early stage lung cancer and transcervical thymectomy.

The overarching goal of Dr. Keller’s Laboratory (kellerlab.stanford.edu) is to improve brain stimulation treatment for neurological and psychiatric disease. Specifically, his lab seeks to improve Transcranial Magnetic Stimulation (TMS) and other brain stimulation techniques by better understanding the fundamental principles of human brain plasticity and building trans-diagnostic real-time monitoring platforms for personalized brain stimulation.

Dr. Casey Gifford's lab is focused on defining the complex genetic and molecular mechanisms associated with congenital heart disease using both rodent and stem cell experimental models.

Dr. Akshay Chaudhari is an Assistant Professor of research in the Integrative Biomedical Imaging Informatics at Stanford (IBIIS) section in the Department of Radiology. His primary research interests lie at the intersection of artificial intelligence and medical imaging. Dr. Chaudhari graduated from UCSD with a B.S. in Bioengineering in 2012. He completed his Ph.D.

Joseph M. DeSimone is the Sanjiv Sam Gambhir Professor of Translational Medicine and Chemical Engineering at Stanford University. He holds appointments in the Departments of Radiology and Chemical Engineering with courtesy appointments in the Department of Chemistry and in Stanford’s Graduate School of Business.

The Stanford Interventional Radiology Translational Theranostics (SIRTT) lab, under Dr. Alexander Vezeridis, is developing next generation therapies using minimally invasive image-guided approaches.

Dr. Grant Rotskoff's research focuses on theoretical and computational approaches to "mesoscale" biophysics. Many of the cellular phenomena that we consider the hallmarks of living systems occur at the scale of hundreds or thousands of proteins. Processes like the self-assembly of organelle-sized structures, the dynamics of cell division, and the transduction of signals from the environment to the machinery of the cell are not macroscopic phenomena—they are the result of a fluctuating, nonequilibrium dynamics.

Dr. Surbhi Sidana specializes in the treatment of plasma cell disorders, such as multiple myeloma, amyloidosis and related disorders. Her research focuses on the development of novel therapeutic approaches, biomarkers and management of treatment toxicity in this field. Dr. Sidana's expertise includes blood and marrow transplantation and CAR-T cell therapy.

Dr. Danny Chou's research program integrates concepts of chemical biology, protein engineering and structure biology to design new therapeutic leads and generate probes to study biological processes. A key focus of the Chou lab is insulin, an essential hormone in our body to reduce blood glucose levels. The lab generates synthetic libraries of insulin analogs to select for chemical probes, and investigates natural insulin molecules (e.g. from the venom of fish-hunting cone snails!) to develop novel therapeutic candidates. Dr.

Dr. Vipul Sheth's research interests are in translational research of magnetic resonance imaging related technologies to improve diagnostics and therapeutics. Specifically, Dr. Sheth has an interest in imaging and characterization of the tumor microenvironment, use of ultrashort echo time in Body MRI applications, and developing synergistic MRI methods to complement PET imaging for applications in PET/MRI. His clinical interests include pelvic floor disorders, pelvic malignancies, whole body MRI and MRI Guided procedures.